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The full-length normal and T24 mutant human H-ras proteins and two truncated derivatives of the T24
mutant were expressed efficiently in Eschenchia coli. The proteins accumulated to 1 to 5% of total cellular
protein, and each was specifically recognized by anti-ras monoclonal antibodies. The two full-length proteins
as well as a carboxyl-terminal truncated derivative (deleted for 23 amino acid residues) were soluble upon cell
lysis and were purified to 90% homogeneity without the use of denaturants. In contrast, an amino-terminal
truncated ras derivative (deleted for 22 amino acid residues) required treatment with urea for its solubilization.
The guanine nucleotide binding activity of these four proteins was assessed by a combination of ligand binding
on proteins blots, immunoprecipitation, and standard filter binding procedures. The full-length proteins
showed similar binding kinetics and a stoichiometry approaching 1 mol of GTP bound per mol of protein. The
carboxyl-terminal truncated protein also bound GTP, but to a reduced extent, whereas the amino-terminal
truncated protein did not have binding activity. Apparently, the carboxyl-terminal domain of ras, although
important for transforming function, does not play a critical role in GTP binding.
The three members of the human ras gene family cH-ras-
1, cK-ras-2, and N-ras encode highly related proteins of 188
to 189 amino acid residues (p21) (3, 19, 21, 31, 37). Both
qualitative and quantitative alterations in these gene prod-
ucts have been implicated in tumorigenesis in animals. In
particular, mutant alleles of these genes which carry point
changes altering amino acid residue 12 or 61 are found in a
variety of tumors and tumor cell lines and, in addition, cause
cellular transformation when introduced into NIH 3T3
fibroblasts (7, 10, 23, 25, 26, 29, 36, 38, 43). Likewise,
elevated expression of apparantly normal ras genes is ob-
served in a spectrum of primary tumors (32, 33) and also may
cause transformation of rodent fibroblasts (4). The ras
proteins are synthesized in the cytoplasm and subsequently
localize to the inner plasma membrane (9, 20, 30, 41). They
appear to undergo posttranslational modification(s) which
includes acylation (28) and results in alteration of their
polyacrylamide gel electrophoretic mobility (11, 20, 30). The
ras proteins selectively bind certain guanine nucleotides (27)
and recently have been shown to hydrolyze GTP to GDP and
Pi (13, 18, 35). This GTPase activity is severely impaired in
products of transforming ras genes, and this deficiency may
be responsible for the transforming activity of these ras
genes.
Detailed biochemical and physical analyses of the ras
proteins have been limited by the low levels of these proteins
produced and obtainable from mammalian cells. One ap-
proach to circumvent these limitations has been to express
the ras proteins in Escherichia coli. Several reports have
described the expression in E. coli of v-ras fusion proteins,
in which the ras polypeptide is fused to some portion of a
procaryotic or synthetically derived sequence (12, 16, 34).
Often the proteins made in this way are found to be
insoluble, and the use of strong denaturants has been re-
quired to obtain them in a soluble form. A recent report
describes the expression of nonfused authentic ras proteins
* Corresponding author.
in E. coli (14). These proteins also were produced in an
insoluble form and required treatment with urea or guanidine
hydrochloride for their solubilization. Both fusion proteins
and proteins which have been treated with strong denatur-
ants may prove unacceptable for detailed analysis of their
protein structure, modification, function, or a combination
of these.
In this report, we describe the efficient expression and
purification of an E. coli-synthesized, authentic, human
wild-type ras gene product and three mutant ras derivatives.
These include the T24 bladder carcinoma-derived ras variant
as well as an amino-terminal truncated and a carboxyl-ter-
minal truncated derivative of the T24 protein. All four
proteins are recognized by a monoclonal antibody produced
against the v-H-ras gene product expressed in cells trans-
formed with Harvey murine sarcoma virus. The normal,
T24, and carboxyl-terminal truncated T24 proteins are solu-
ble upon cell lysis and were purified without the use of
chaotropic agents. All three of these proteins bind guanine
nucleotides. In contrast, the amino-terminal truncated T24
protein is found to be insoluble in E. coli and exhibits no
binding activity.
MATERIALS AND METHODS
Reagents. Commercial reagents and their suppliers were:
enzymes for cloning and characterization, New England
BioLabs, Inc., Bethesda Research Laboratories, Inc., and
Boehringer Mannheim Biochemicals; agarose, FMC Corp.,
Marine Colloids Div.; acrylamide reagents, Bio-Rad Labo-
ratories and J. T. Baker Chemical Co.; nitrocellulose, Schl-
eicher & Schuell Inc.; protein A-Sepharose, Pharmacia Fine
Chemicals; rabbit anti-rat immunoglobin G (IgG) (H+L),
Cappel Laboratories; lysozyme and Freund adjuvants, Sigma
Chemical Co.; [a-32P]dGTP and riboguanosine 5'-
triphosphate (rGTP) (15 TBq/mmol), 125I-protein A (1,332
GBq/mg), [35S]methionine (52 TBq/mmol), and [3H]rGDP
(392 GBq/mmol), Amersham Corp. Enzymes were used ac-
cording to the specifications of the manufacturers. For ol-
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HUMAN H-ras PROTEINS EXPRESSED IN E. COLI 1017
igonucleotide synthesis, the silica gel solid support was ob-
tained from Applied Biosystems, the protected nucleosides
were from Cruachem Chemical Co., and all other reagents
were from Aldrich Chemical Co. The hybridoma cell line
producing the rat Y13-259 antibody directed against Harvey
murine sarcoma virus p21 (11) was kindly provided by Mark
Furth. Antibody was recovered from serum-free culture su-
pernatants by ammonium sulfate precipitation.
Synthesis of oligonucleotide linkers. The linkers used in the
plasmid constructions (Fig. 1) were synthesized on a silica
gel polymer support (Fractosil) by the phosphite-triester
procedure previously described (39) with some modifica-
tions. The solution containing the active phosphorylating
derivative of the incoming nucleoside was passed through a
column packed with derivatized silica gel to produce the
coupled phosphite intermediate which was then oxidized to
the phosphate form with aqueous iodine. The unreacted
5'-OH group was capped with a mixture of acetic anhydride,
pyridine, and 4-dimethylaminopyridine. The dimethoxytrityl
group was removed with 3% trichloroacetic acid in methy-
lene chloride. After being washed with chloroform followed
by pyridine, the resin was ready for the next cycle (cycle
time was 15 min). At the end of the synthesis, the resin was
removed from the column and treated with concentrated
ammonium hydroxide to cleave the oligomer from the resin
and to remove the protecting groups. After centrifugation,
the ammonia solution was concentrated, and the residue was
dissolved in water and purified on a 20% polyacrylamide gel.
The oligomer was recovered from the gel by electrophoretic
elution onto Whatman DEAE-81 paper, followed by elution
with 1 M triethylammonium bicarbonate (pH 8.5). The
triethylammonium bicarbonate was removed by coevapora-
tion with water, and the sample was dissolved in water. The
sequence of the oligomers was verified by a modification of
the Maxam and Gilbert procedure (17). For cloning, com-
plementary strands were mixed in an equal molar ratio in
0.01 M NaCl, heated to 65°C, and then allowed to cool to
room temperature.
Plasmid constructions. (i) Human H-ras cDNA plasmids.
Plasmids containing the complete protein coding and 3'
noncoding sequences of the human normal (pPPS3) and T24
(pPPS22) H-ras genes were constructed (not shown) by
splicing together previously described cDNA (6) and ge-
nomic (38) H-ras clones. The cDNA plasmid pRS6 contains
the complete protein coding region of the transforming T24
H-ras gene (valine in place of glycine at amino acid position
12) but lacks part of the 3' noncoding sequence and has an
apparent non-ras sequence upstream of the ATG initiation
codon (6). The 3' region was completed by substituting a
PstI fragment of PRS6 with the corresponding fragment of
pRS3 (6) which contains an intact 3' untranslated region and
polyadenylic acid sequence. The cDNA sequence in the
resultant plasmid, pRC1, was excised at the PvilII (between
codons 22 and 23) and Sall (end of the polyadenylic acid
sequence) sites and inserted into the corresponding sites of
pBR322 to yield pPS11. The 5' region was completed by
cleaving pPS11 with PvuII and inserting a 179-base-pair (bp)
PvuII fragment from the first exon of the genomic clone
pT24, which carries the complete T24 variant H-ras gene on
a 6.2-kilobase BamHI fragment. This PvuII fragment ex-
tends from codon 22 to 113 bp upstream of the ATG and
encodes valine at position 12. The resultant plasmid pPPS22
is shown in Fig. 1. The corresponding plasmid encoding the
normal H-ras cDNA, pPPS3 (Fig. 1), was obtained by
inserting the 179-bp PvuII fragment from the normal H-ras
gene clone pP3 (38). This PvuII fragment encodes glycine at
position 12.
(ii) pMG27N expression vector. The 5.8-kilobase expres-
sion vector pOT1 (5) was digested with EcoRI, filled in with
E. coli DNA polymerase Klenow fragment, and then par-
tially digested with BalI (Fig. 1). The 5-kilobase EcoRI-BalI
fragment, isolated by polyacrylamide gel electrophoresis
(PAGE) and electroelution, was incubated overnight with T4
DNA ligase to yield pMG27. Plasmid pMG27 was partially
digested with NdeI, filled in, and ligated to yield pMG27N.
Plasmid pMG27N has a single NdeI site encompassing an
ATG initiation codon located 8 bp downstream of the Cl,
ribosome binding site.
Bacterial growth, induction, and pulse-labeling. The
pSKcHras, pSKT24, pSKT24t1, and pSKT24t2 expression
plasmids were maintained in cI+ hosts. For expression the
plasmids were transferred into E. coli K-12 N5151 or AR58
(J. Auerbach, unpublished data) carrying the c1857(Ts) mu-
tation (24). The cells were grown at 32°C to an optical
density at 650 nm of 0.4 (strain N5151) or 0.6 (strain AR58)
and induced by rapidly increasing the temperature to 42°C.
Pulse-labeling with [35S]methionine was performed as previ-
ously described (24). At the indicated times after induction,
200-,ul samples of the culture were pulse-labeled with 20 ,uCi
of [35S]methionine for 45 s, and the cell lysates were ana-
lyzed by sodium dodecyl sulfate (SDS)-PAGE (15). Large-
scale fermentations (4 to 10 liters) were performed as previ-
ously described (24). Cell pellets were stored at -70°C.
Purification of ras proteins. Induced AR58 cells containing
the normal, T24, or carboxyl-terminal truncated T24 pro-
teins were resuspended in 7 volumes of buffer X (20 mM
Tris-acetate [pH 7.5], 0.1 mM EDTA, 1 mM MgCl2, 0.1 mM
ATP, 1.0 mM 2-mercaptoethanol [2-ME]) at 0°C and
lysozyme was added to a concentration of 0.2 mg/ml. After
30 min, phenylmethylsulfonyl fluoride (0.2 M in methanol)
was added (final concentration, 1 mM), and the viscosity of
the sample was reduced by sonication. Cell debris was
FIG. 1. Construction of vectors for the expression of the full-length normal and T24 mutant H-ras proteins. For the construction of
pSKT24 a synthetic, double-stranded oligonucleotide encoding amino acid residues 6 to 10 of H-ras was ligated into pUC9 between the
HindIlI and Narl sites. The resultant plasmid, pUC49, was cleaved with Narl and ligated with a 900-bp NarI fragment isolated from the T24
ras cDNA plasmid pPPS22 to give pUC59. To complete the reconstruction of the amino terminus, a second synthetic oligonucleotide was
introduced into pUC59 at the HindIll site. The oligomer bearing the Ndel half site was first phosphorylated with T4 DNA kinase before
annealing with its complementing strand. This singly phosphorylated, double-strand oligonucleotide was ligated with HindIll-cleaved pUC59.
Digestion of the resultant plasmid, pUC69, with Ndel and Sall gave an 800-bp fragment containing the complete amino acid and 3'
untranslated sequences of the T24 ras allele. This fragment was inserted into pMG27N between the corresponding sites to yield pSKT24. The
amino-terminal protein coding sequence and vector-insert boundary were verified by Maxam-Gilbert DNA sequencing. For the construction
of pSKcHras the normal ras cDNA clone pPPS3 was digested with Narl, and the 900-bp fragment encoding all but the initial 10 amino acids
was isolated. Similarly, pUC69 was cleaved with Narl, and the large vector fragment containing the initial 10 ras codons was isolated.
Ligation of these two Narl fragments yielded plasmid pUC69wt. The complete normal ras coding sequence was excised on an NdeI-SaIl
fragment and ligated into the corresponding sites of pM627N to yield the expression vector pSKcHras. The construction of the human ras
cDNA plasmids pPPS3 and pPPS22 and the pMG27N expression vector is described in the text.
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removed by centrifugation at 37,000 x g for 30 min, and
ammonium sulfate was added to the supernatant to 60%
saturation. The ammonium sulfate pellet was collected by
centrifugation, dissolved in buffer X, and applied to an AcA
34 column. Fractions containing ras protein, identified by
protein blotting and GTP binding assays, were pooled and
applied to a DEAE-Sephacel column equilibrated with buffer
X containing 20 mM NaCl. The column was eluted with a
linear 20 to 300 mM NaCl gradient in buffer X. The ras
proteins eluted at 170 to 200 mM NaCl. With judicious
pooling of the AcA and DEAE column fractions, the normal,
T24, and C-terminal truncated ras proteins were obtained at
about 90% homogeneity in about a 20% overall yield. The
actual amount of the pure proteins recovered per gram of
packed frozen cells was about 0.3 mg for the T24 and
carboxyl-terminal truncated T24 proteins and about 0.15 for
the normal product. Protein concentrations were measured
with the Bio-Rad protein assay, using blue dye reagent and
bovine serum albumin (BSA) as the standard (2). The
molecular concentration of one highly purified sample
(>95%) was determined by quantitative amino acid analysis,
and the concentrations of the other preparations were then
estimated from their relative purity as measured by SDS-
PAGE. Amino acid sequencing of the normal and T24
proteins verified their predicted sequence through the initial
15 amino-terminal residues. For purification of the amino-
terminal truncated H-ras protein, induced cells were lysed
and centrifuged as above. Essentially all of this ras protein
was found in the pellet. The pellet was successively ex-
tracted with buffer B (50 mM Tris-hydrochloride [pH 8], 2
mM EDTA, 0.1 mM dithiothreitol, 5% glycerol) containing
0.05% deoxycholate, 1.5 M NaCl, and then 1.5% oc-
tylglucopyranoside. The T241 protein was then solubilized
with 4 M urea in buffer B containing 0.01% Nonidet P-40.
The protein remained soluble after dialysis against buffer B
containing progressively lower urea and higher Tris-hydro-
chloride concentrations, ending with buffer B plus 0.2 M
Tris-hydrochloride. This protein preparation which was
about 60 to 70% pure by SDS-PAGE was used to prepare
rabbit polyclonal antibody.
SDS-PAGE and immunoblot analysis. Cell extracts and
partially purified ras proteins were incubated at 95°C for 5
min with gel loading buffer (60 mM Tris-hydrochloride [pH
8.7], 0.7 M 2-ME, 2% SDS, 10% glycerol) and analyzed by
SDS-PAGE on a 15% gel. For dGTP binding assays on
protein blots, samples of the purified proteins were not
heated before loading on the gel. (rGTP and dGTP compete
about equivalently for the GTP binding site of the ras protein
[27; unpublished data]. The use of [ox-32P]dGTP in these
initial assays was determined by availability.) For im-
munoblot analysis, the proteins were electrophoretically
transferred to nitrocellulose in 25 mM Tris-192 mM
glycine-20% methanol for 2 to 6 h at 200 mA with a Bio-Rad
Transblot apparatus. The protein blot was rinsed twice in
phosphate-buffered saline for 5 min each and then treated
successively as follows: 3% BSA in phosphate-buffered
saline for 1 h at 25°C; RIPA (20 mM Tris-hydrochloride [pH
7.5], 150 mM NaCl, 1 mM EDTA, 0.5% Triton X-100, 0.1%
SDS) twice for 2 min each at 25°C; monoclonal antibody
Y13-259 in RIPA for 45 min at 37°C; rabbit anti-rat IgG in
RIPA for 30 min at 37°C; 125I-protein A in RIPA for 20 min
at 37°C; RIPA rinse five times for 5 min each at 37°C.
GDP-dGTP binding assays. (i) Immunoprecipitation. As-
says were carried out at 4°C in 100 ,ul of buffer A (20 mM
Tris-hydrochloride [pH 7.4], 100 mM NaCl, 5 mM MgCl2)
containing 1% Triton X-100 and 10 ,uM [3H]GDP (1 Ci/mmol)
or [a-32P]dGTP (1 Ci/mmol) essentially as described by
Furth et al. (11). The protein sample was added to the assay
solution and incubated for 20 min. The primary antibody
(rabbit anti-T24t1, prebled antiserum or rat monoclonal 259)
was added for 30 min, followed by rabbit anti-rat IgG (in
assays with the monoclonal antibody) for 30 min and then by
protein A-Sepharose beads for 1 h with mixing. The beads
were then washed extensively with buffer A, eluted by
heating at 95°C for 5 min with gel loading buffer, and
centrifuged. A portion of the eluted sample was counted in a
scintillation counter.
(ii) GTP binding on a protein blot. After SDS-PAGE and
electrotransfer as described above, the protein blots were
incubated successively in the following solutions with gentle
agitation: 3% BSA in phosphate-buffered saline containing 5
mM sodium PP, for 1 h at 25°C, twice in buffer A for 15 min
at 4°C, and finally in buffer A containing 5 mM [ox-32P]dGTP
(2.7 Ci/mmol) and 1 mM sodium PP, for 30 min at 4°C.
Monoclonal antibody 259 was added for 30 min at 4°C,
followed by the addition of rabbit anti-rat IgG for 20 min at
4°C. Then the blot was washed five times with buffer A
containing 1 mM sodium PP, at 4°C.
(iii) Filter binding. The normal and T24 protein samples
were incubated with [a-32P]GTP in buffer A containing 0.12
M ammonium sulfate at 25°C. Samples of these reactions
were added to 2 ml of buffer A at 4°C containing 10 p,g of
BSA per ml. The samples were filtered through nitrocellu-
lose (pore size, 0.45 ,um) and washed with 20 ml of buffer A.
The filters were counted in a scintillation counter at settings
for Cerenkov radiation.
Antibody preparation. Polyclonal antibody directed against
the purified amino-terminal truncated protein (T24t,) was
prepared in New Zealand White rabbits. Rabbits were
injected subscapularly at 10-day intervals, and the antibody
was titrated by an enzyme-linked immunosorbent assay
procedure with goat anti-rabbit IgG conjugated to horserad-
ish peroxidase.
RESULTS
Vector constructions for the expression of normal and
mutant ras proteins. The constructions of the plasmid vec-
tors for the expression of the authentic normal (pSKcHras)
and T24 variant (pSKT24) human H-ras gene products are
diagrammed in Fig. 1. The basic expression vector, pOT1
(5), is a derivative of pAS1 (24) and uses transcriptional and
translational control elements derived from phage lambda to
regulate expression of inserted foreign genes. We further
modified the pOT1 vector by deleting three of its four NdeI
restriction sites (Fig. 1). The resulting vector, pMG27N,
retains a single NdeI site which overlaps the translation
initiation codon (CATATG) provided on the vector. Plas-
mids containing the complete protein coding sequences of
the human normal (pPPS3) and T24 (pPPS22) H-ras genes in
a cDNA configuration were constructed by splicing together
cDNA (6) and genomic H-ras (38) clones as described above
(Fig. 1).
To introduce the complete T24 ras coding sequence into
pMG27N at the unique NdeI site, we first reconstructed the
N-terminus of the T24 ras cDNA with synthetic oligonu-
cleotide linkers. Two overlapping linkers were used to
replace the first 28 bp of the ras gene sequence and to
position an NdeI site at the initiation codon (Fig. 1). The
linker sequences also introduced nucleotide changes into the
ras coding sequence; however, none of these changes al-
tered the amino acid sequence encoded by the gene. The
nucleotide changes created codons which were more fre-
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FIG. 2. Construction of vectors for the expression of truncated
H-ras proteins. A. For the construction of pSKT24T, plasmid
pPPS22 was cleaved with PvuII and SalI, and the 800-bp fragment
lacking the initial 22 codons was isolated. The expression vector
pOT1 was digested with BamHI and subsequently treated with mung
bean nuclease to create a flush end terminating with ATG. The
vector was cleaved with Sall and ligated with the 800-bp ras
fragment to yield the pSKT24t, expression plasmid. The ras coding
sequence is deleted in frame between codons 1 and 23. B. For the
construction of pSKT24t2 the activatec ras plasmid pUC69 was
quently used by E. coli and also introduced a unique HindIII
restriction site at position 13 in the T24 ras gene sequence.
The remainder of the ras coding sequence, extending from a
unique NarI site, was obtained from the T24 cDNA plasmid
pPPS22. The reconstructed ras coding sequence was excised
on an NdeI-SalI DNA fragment and inserted into the corre-
sponding NdeI and SalI sites on pMG27N. Direct DNA
sequencing verified that the synthetic 5' terminus of the gene
and the junctions of the insert on the final expression vector,
pSKT24, were correct. The corresponding plasmid contain-
ing the wild-type H-ras allele, pSKcHras, was made by
exchanging a DNA segment, which included the T24 muta-
tion, with the same DNA segment obtained from plasmid
pPPS3 containing the normal ras cDNA sequence (Fig. 1).
The final ras expression vectors are thus identical, except
for a sequence difference at position +34 (guanine versus
thymine, glycine in wild type versus valine in T24 at codon
12) of the ras coding sequence. We also constructed vectors
for the expression of an amino-terminal truncated and a
carboxyl-terminal truncated derivative of the T24 ras gene.
Plasmid pSKT24t, encoding the amino-terminal deletion was
constructed by inserting a PvuII-SalI fragment from pPPS22
directly into the pOT1 expression vector between the BamHI
and Sall sites (Fig. 2A). The BamHI site of the vector was
first blunt ended with mung bean nuclease (24), thereby
allowing direct fusion of the PvuII end of the fragment
insert. This fusion places codon 23 of ras in frame with the
ATG initiation codon provided on the vector and thus leads
to expression of a variant ras protein deleted between amino
acid residues 1 and 23 (T24g,). Vector pSKT24t2 expressing
the carboxyl-terminal deletion was constructed by first in-
troducing a linker encoding a TGA termination signal after
amino acid residue 166 in pUC69. This ras sequence, deleted
of 23 C-terminal residues, was then transferred to the
NdeI-SaII window of the pMG27N expression vector (Fig.
2B).
Expression of wild-type and variant ras proteins. The ras
expression plasmids pSKcHras, pSKT24, pSKT24t,, and
pSKT24t2, as well as the control vector pMG27N, were
transfected into E. coli lysogens, which carry a defective
prophage encoding a temperature-sensitive repressor (cl857).
Cultures were grown at 32°C and induced at 42°C, and
protein expression was initially examined by pulse-labeling
with [35S]methionine. Each of the ras vectors selectively
induced the synthesis of a prominent labeled 20 to 22-
kilodalton (kDa) protein, which was absent in cultures
containing the control vector (Fig. 3, results for pSKT24t2
are not shown). The induced products were identified di-
rectly as ras proteins by an immunoblot (i.e., Western)
analysis with a monoclonal antibody (11) developed against
the viral H-ras protein. Total induced bacterial lysates were
fractionated by SDS-PAGE and transferred electrophoretic-
ally to nitrocellulose paper. The Western analysis (Fig. 4)
identified the same 20- to 22-kDa protein bands observed in
the pulse-labeling experiments.
restricted with NcoI and Sau3A, and a 156-bp fragment was gel
purified. A linker was synthesized to reconstitute exactly the DNA
sequence from the Sau3A site (amino acid 161 to 162) to DNA
position 501 (amino acid 166). Codon 167 was replaced with a
termination signal (TGA). The vector was prepared by restricting
pUC69 with NcoI and SmaI. The final construction of the carboxyl-
terminal truncated T24 gene was achieved by ligation of the 156-bp
NcoI-Sau3A fragment, the Sau3A-TGA linker, and the NcoI-SmaI
vector fragment.
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FIG. 3. [35SJmethionine pulse-labeling. Cultures of E. coli AR58 containing the designated plasmids were assayed at the indicated times
after heat induction for the synthesis of ras proteins by pulse-labeling with [35S]methionine (see the text). The zero-time sample was taken
just before induction. Equivalent amounts of acid-precipitable radioactivity were loaded in each lane. The gel was dried and exposed in direct
contact with Kodak XAR film at -20°C. The arrow marks the unique induced bands at about 22,000 kDa.
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FIG. 4. Identification of ras proteins with anti-vH-ras mono-
clonal antibody. At the indicated times, the optical density at 650 nm
of cultures of N5151 containing the designated plasmids was meas-
ured, and 1-ml samples were removed and centrifuged at 10,000 x g
for 1 min. The cell pellets were solubilized, and an equivalent of
0.006 unit (optical density at 650 nm) of cells was fractionated by
SDS-PAGE and on a 15% gel and assayed for ras protein by an
immunoblot procedure (see the text). The purified T24 protein (40
ng) was included as a reference. The processed blot was exposed to
X-ray film for 8 days at -70°C with an intensifying screen. kd, kDa.
To examine the stability of the various ras gene products
in E. coli, we carried out pulse-chase-labeling experiments.
Induced cultures were pulse-labeled with [35S]methionine
for 1 min and then chased with excess unlabeled methionine
in the presence of chloramphenicol. Samples were examined
at various times after the chase. The results (data not shown)
indicate that the four different ras proteins have similar
stabilities in E. coli with a half-life of approximately 10 to 15
min. We examined several different E. coli K-12 strains for
their ability to synthesize and stabilize the ras proteins, and
all were found to exhibit similar levels of expression.
The efficient expression of all four ras gene constructs
resulted in the accumulation of sufficient protein to enable
the development of a simple and rapid protocol for ras
purification (detailed above). Of note, upon lysis the wild-
type, T24, and T24t2 ras proteins were found exclusively in
the soluble portion of the cell extract. Curiously, the full-
length ras proteins produced in other E. coli expression
systems are insoluble and require the use of strong denatur-
ants to obtain them in soluble form (14). Only our N-terminal
truncated ras derivative, T24tj, was found to be insoluble
upon initial cell lysis and required the use of denaturants for
its solubilization. However, upon removal of the urea by
dialysis, this truncated derivative remains soluble (see
above). A gel profile of the purified normal, T24 and T24tj,
proteins is shown in Fig. 5. The difference in the mobilities
of the purified normal and T24 proteins in SDS-denaturing
gels is consistent with previous comparisons of similar
proteins produced in mammalian cells (11, 20, 30). Thus, this
altered mobility is a consequence of primary sequence rather
than differential modification in mammalian cells. Corre-
sponding results were reported recently by Lacal et al. (14).
We also note that the mobility of T24t, is similar to that of
T24, although the former is presumably deleted of 22 ami-
no-terminal residues (Fig. 3). We have not directly deter-
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HUMAN H-ras PROTEINS EXPRESSED IN E. COLI 1021
mined the amino or carboxy terminus of the T24t1 protein,
but based on our experience with other proteins expressed
from pAS-1 or derivative vectors, we think it unlikely that
the T24t1 differs from its predicted primary sequence. We
thus presume that the aberrant migration of T24t, results
from conformational properties in SDS.
Guanine nucleotide binding of the wild-type and T24 ras
proteins. One well-characterized biochemical property of the
ras proteins is their ability to selectively bind certain guanine
nucleotides (e.g., GTP, GDP, and dGTP). We have utilized
three different procedures to assess the guanine binding
properties of our bacterially produced ras proteins. First, we
developed a simple qualitative ligand binding assay which
can be applied either to complex protein mixtures such as
total E. coli cell lysates or to purified preparations of the ras
proteins. In addition, this assay allows analysis of both
soluble and insoluble protein preparations. The protein(s)
was resolved by SDS-PAGE, transferred to nitrocellulose,
and then incubated with [ox-32P]dGTP and the ras antibody
(see above for details). Both the wild-type and T24 proteins,
in whole cell extracts or as purified proteins, bound dGTP
(Fig. 6A and B).
The second assay uses an immunoprecipitation procedure
(27) to examine ras-related guanine nucleotide binding.
Soluble protein extracts were prepared from induced cul-
tures producing the wild-type and T24 proteins. Portions of
these extracts were incubated with [3H]GDP or [a-32PJdGTP
and subsequently immunoprecipitated with antibody and
protein A-Sepharose (see above). The results (Table 1)
indicate that both the normal and T24 proteins exhibit
GDP-dGTP binding. This binding was competed selectively
by GTP and not by ATP. In this assay only about 10 to 20%
of our ras protein exhibited binding; however, this does not
reflect saturation values and thus is only a minimum estimate
of binding efficiency.
Our ability to purify milligram quantities of both the
wild-type and T24 proteins allowed us to accurately measure
GTP binding by a nitrocellulose-filter retention assay (see
above). We compare the binding kinetics of these two
proteins by this assay (Fig. 7). The results show that the T24
protein exhibits a two- to threefold-slower initial rate of
binding than does the normal p21, although both proteins
N
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FIG. 5. SDS-PAGE profile of purified normal, T24, and carboxyl-
terminal truncated (T24t.) proteins. Each lane contained about 1.5
,ug of the indicated protein purified through the DEAE-Sephacel
step (see the text). kd. kDa.
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FIG. 6. dGTP binding to the normal and T24 polypeptides on
protein blots. A. Samples of the solubilized cells described in the
legend to Fig. 4 (0.06 unit [optical density at 650 nm] of cell culture)
were electrophoresed on a 15% acrylamide gel, transferred to
nitrocellulose, and assayed for [ct-32P]dGTP binding as detailed in
the text. The film was exposed at -70°C with an intensifying screen
for 7 days. B. About 0.4 ,ug of the purified normal, T24, and T24t,
proteins were processed as described for panel A. The film was
exposed for 3 days. kd, kDa.
attain equivalent equilibrium binding. This difference be-
tween the two proteins indicates that the substitution of
valine at position 12 causes a subtle alteration of the GTP
binding site. The amount of GTP bound was about 0.7
mol/mol of p21 (the protein concentration was determined
by quantitative amino acid analysis). This value represents
saturation binding since comparable results were obtained
even at a 20-fold-lower GTP concentration (not shown). In
TABLE 1. Immunoprecipitable guanine nucleotide binding
activity
pmol of
Sample" nucleotideb
bound
Expt 1
T24
- 259 0.4
+ 259 7.9
+ 18-7 prebleed 0.2
+ 18-7 Ab 8.2
H-ras
- 259 0.1
+ 259 17.8
BSA (20 ,ug) 0.2
Expt 2
T24
- 259 0.5
+ 259 9.6
+ 259, 80 mM rGTP 3.6
+ 259, 100 mM rATP 9.5
BSA (20 jig) 0.2
a Lysates of AR58 cells containing the H-ras or T24 proteins were purified
through the ammonium sulfate step, and then 2-VI samples were assayed for
immunoprecipitable guanine nucleotide binding as described in the text. The
fractionated lysates (10 ml) were prepared from 10 g of the H-rais or from 4 g of
the T24 cell pellets. 259. Monoclonal antibody Y13-259; 18-17 prebleed.
preimmunization rabbit sera; 18-17. Ab, anti-T24t,. rabbit antisera.
b [3HJrGDP in experiment 1; [a-_2PJdGTP in experiment 2.
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FIG. 7. GTP binding kinetics of purified ras proteins. The normal
(100 nm, 0), T24 (120 nM, A), and C-terminal truncated T24 (250
nM, O) proteins were incubated with 10 ,uM [a-32P]GTP (2 Ci/mmol)
in buffer A-0.12 M ammonium sulfate at 250C. Duplicate 20-,ul
portions were removed at the indicated times and assayed for GTP
bound to protein by filtration through nitrocellulose (see the text).
The molar concentration of the ras proteins was estimated as
described in the protein purification section of the text.
other assays we have determined that the efficiency of
retention on nitrocellulose is only 70 to 80% (35). Thus, most
(if not all) of our purified wild-type and T24 mutant ras
proteins are capable of guanine nucleotide binding.
Guanine nucleotide binding of the ras truncates. Since the
N-terminal truncated protein is expressed in an insoluble
form, we assessed its GTP binding activity only by the
protein blot-ligand binding assay. This assay allows us to
compare directly the qualitative GTP binding of this N-ter-
minal truncate with the full-length forms of ras because
whole cell extracts are examined after identical treatment.
The T24t1 protein showed no binding activity under condi-
tions in which both the full-length normal and T24 products
did bind GTP (Fig. 6).
In contrast, the C-terminal truncated ras derivative, T24t2,
does retain its GTP binding activity. As mneasured by the
filter binding assay (Fig. 7), the kinetics of binding are
similar to those of the full-length T24 product; however, the
overall extent of binding is significantly reduced. This non-
stoichiometric binding was not altered by increasing the
GTP concentration fivefold (not shown), suggesting that only
a fraction of our purified protein preparation is active.
Nonetheless, these results suggest that the carboxyl-termi-
nal 23 amino acids of ras are not essential for its GTP binding
ability.
DISCUSSION
We described the construction of E. coli expression vec-
tors which encode the authentic wild-type human H-ras
protein, its T24 variant, and two differeht truncated forms of
the T24 protein. One of the T24 truncated proteins, T24tj,
was deleted between residues 1 and 23 at the amino termi-
nus, whereas the other truncated protein, T,24t2, was deleted
for 23 C-terminal residues. To precisely irltVoduce the wild-
type and T24 cDNA sequences iAto the expression vector,
the 5' end of the ras gene was reconstructed with synthetic
linkers. In doing so, we inserted a unique HindIll restriction
site at codon positions 4 and 5 in the human gene without
altering the amino acid coding sequence. Creation of this
restriction site provides a new entry site into the N-terminal
sequence of the human gene which has been useful for
making additional gene alterations. In addition, we made
several codon changes within this region of the gene to
introduce codons more frequently used in E. coli. The four
different ras gene constructs were shown to express effi-
ciently in E. coli, and the ras products accumulated to levels
ranging from 1% (cH-ras) to 5% (T24t1) of total cellular
protein. Pulse-chase analyses indicated approximately equiv-
alent half-lives for these proteins, although these assays
would not readily detect a 1.5- to 2-fold difference. Thus, the
efficiency of transcription or translation, or both, of these
plasmids probably differs slightly. The induced protein prod-
ucts were shown to be ras related by immunoblot analysis
with a monoclonal antibody raised against the authentic
mammal-derived p21 protein (Fig. 4).
The wild-type, T24, and T24t2 (C-terminal truncated)
proteins were produced in soluble form in E. coli and were
purified to homogeneity without the use of chaotropic agents.
Only the T24t1 (N-terminal truncated) protein was found to
be insoluble in crude cell lysates and required treatment with
urea for its initial solubilization. This report constitutes the
first description of an extensive purification of nonfused ras
proteins from bacteria without denaturation of the protein.
We point this out to emphasize our concern that the bio-
chemical, physical, and biological characteristics of proteins
which are fused to other proteins, denatured during their
isolation, or both may not accurately reflect the properties of
the native protein. As evidenced above, this does not appear
to be the case with the proteins described here.
We used our purified ras protein preparations to charac-
terize certain biochemical parameters, as well as biological
activities, of these E. coli-synthesized molecules. In this
report, we described the guanine nucleotide binding capabil-
ities of these proteins. We demonstrated (by several different
assay systems) that the full-length ras wild-type and T24
variant proteins appropriately bind certain guanine nucleo-
tides and that the stoichiometry of nucleotide binding was
essentially equimolar. This quantitative assessment of nucle-
otide binding was made possible only because of our ability
to obtain these proteins in a sufficient quantity and in pure
enough form to assay by standard nitrocellulose filter bind-
ing techniques. Moreover, we found that the C-terminal
truncated ras protein retained its ability to bind GTP,
although the extent of binding was reduced. Apparently, the
C-terminal 23 anlino acid residues are not a crucial part of
the nucleotide binding site. This C-terminal truncate, how-
ever, has lost its transforming ability (unpublished data).
Willumsen et al. (42) have shown that mutations in the
C-terminal portion of ras dramatically reduce its transform-
ing ability and result in the inability of ras to localize
properly to the inner cell membrane. Our results are consis-
tent with these conclusions and further suggest that C-ter-
minal altered molecules will retain their nucleotide binding
capabilities. Ih contrast to the results obtained with the
C-terminal truncate, we found that the N-terminal truncate
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was completely deficient in nucleotide binding. Since this
protein was insoluble upon initial lysis of the cells, our
conclusion is based only on comparing its guanine binding
ability to that of the other three ras proteins by the qualita-
tive Transblot ligand binding assay (Fig. 6). The inability of
this derivative to bind nucleotide is consistent with protein
modeling studies (22, 40) which implicate the region around
amino acid 12 as part of the nucleotide binding site.
It recently was reported (35) that the normal ras protein,
synthesized and purified as described in this report, has an
intrinsic GTPase activity which yields GDP and Pi. In
contrast, the T24 transforming derivative was markedly
deficient in this activity. Presumably, this defect is respon-
sible for its transforming properties. Preliminary data sug-
gest that the C-terminal truncate, described here, exhibits
GTPase properties similar to those found for the full-length
T24 derivative. This result further suggests that the carboxyl
end of ras does not play a critical role in either GTP binding
or GTP catalysis.
It also has been demonstrated that E. coli-produced and
-purified ras proteins exhibit authentic biological activities
when they are introduced into mammalian cells (8). The T24
oncogenic form of ras caused rapid morphological changes
and induced cell proliferation when microinjected into qui-
escent, confluent NRK, REF52, and NIH 3T3 rodent cells.
In contrast, the wild-type protein exhibited little, if any,
effect on these cells. We conclude that the ras proteins
synthesized in E. coli are appropriate substrates for studying
both the biochemical and biological activities of these mol-
ecules. We have thus undertaken the purification of suffi-
cient pure protein for crystallographic analysis of both the
wild-type and T24 variant proteins.
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